<DOC>
	<DOCNO>NCT02033629</DOCNO>
	<brief_summary>The development target effect-site controlled concentration ( TCI ) remifentanil gain increase acceptance cardiac surgery regard result hemodynamic stability early extubation . The use low-dose opioid technique progressively use nowadays ceiling effect attenuate cardiovascular response noxious stimulus . We hypothesize use low target remifentanil effect site concentration may provide comparable short time tracheal extubation hemodynamic stability use high remifentanil Ce target-controlled propofol anesthesia cardiac surgery .</brief_summary>
	<brief_title>Low Remifentanil Target Controlled Infusions Cardiac Surgery</brief_title>
	<detailed_description>Reducing time tracheal extubation hence duration postoperative mechanical ventilation could lessen postoperative complication , improve patient ' outcome , shorten intensive care unit ( ICU ) stay , reduce cost treatment . Although high-dose opioid cardiac anesthesia show provide hemodynamic stability adequate depth anesthesia response nociceptive stimulation , may cause delayed recovery lengthen duration postoperative ventilation support ( ICU length stay . The pharmacokinetic-based drug infusion system , target-controlled infusion ( TCI ) , rapidly easily enable change maintenance constant blood concentration intravenous anesthetic drug . We demonstrate , use TCI sufentanil effect-site concentration ( Ce ) 0.2 0.3 ng/mL TCI propofol anesthesia valve surgery shorten time clinical recovery extubation . Remifentanil , short-acting opioid-receptor agonist context-sensitive half-time 3 5 minute allow rapid emergence anesthesia , even infusion several hour . Compared sufentanil ( 0.03 0.04 µg/kg/min ) , use remifentanil ( 0.5 1.0 µg/kg/min ) propofol anesthesia improve recovery pulmonary function shorten postoperative hospital length stay coronary artery bypass grafting ( CABG ) . Furthermore , TCI remifentanil Ce 1.5-5.0 ng/ml effective constant-rate infusion inhibition stress response maintenance cardiac autonomic nervous system balance off-pump CABG . Similarly , low remifentanil Ce use another study explicit implicit memory cardiac surgery TCI propofol 2 4 ng/ml . Whereas , others use wide range remifentanil Ce 2 10 ng/ml . However , use high remifentanil Ce 7 ng/ml ( equivalent 0.3 ng/kg/min ) associate long time extubation sufentanil Ce 0.3 ng/ml ( 256 ( 92 ) vs. 161.9 ( 32.9 ) min , respectively ) .This preclude favorable unique pharmacokinetic characteristic remifentanil . Thus use low target control infusion remifentanil could allow fast time extubation reduce overall cost anesthetic . We hypothesize use low remifentanil target-controlled Ce TCI propofol anesthesia cardiac surgery could decrease time tracheal extubation . The subject allocate randomly 3 group draw sequentially number seal opaque envelope contain software-generated randomization code . The patient monitor pulse oximeter , 5-lead electrocardiograph ( lead II V5 ) continuous ST-segment recording , radial mean arterial blood pressure ( MAP ) measurement , end-tidal carbon dioxide measurement , central venous catheter pulmonary artery catheter ( accord discretion attend anesthesiologist ) , rectal nasopharyngeal temperature measurement . Significant ischemic response define reversible ST-segment change baseline , namely ≥1-mV ST-segment depression ≥2-mV ST segment elevation last ≥1 minute . Response entropy ( RE ) state entropy ( SE ) monitor apply entropy electrode ( Datex-Ohmeda Division , Instrumentarium Corporation , Helsinki , Finland ) accord manufacturer 's recommendation . An independent anesthesiologist involve collect patient data initiate remifentanil Ce ( model Minto et al ) accord patient 's randomization code allow titrate target propofol remifentanil Ce administer vasoactive medication need . After preoxygenation , anesthesia induction simultaneous target propofol remifentanil infusion use TCI system syringe pump ( Injectomat TIVA Agilia , Fresenius Kabi , France ) . The target propofol Ce ( model Schnider et al 13 ) initiate 1.0 µg/mL titrate stepwise 0.5 µg/mL every 3 minute loss consciousness SE &lt; 50 difference &lt; 10 RE SE ( RE-SE ) achieve . Cisatracurium , 0.2 mg/kg , give facilitate tracheal intubation , lung ventilate fraction inspire oxygen 0.5 maintain normocapnia . The time induction intubation record . Anesthesia maintain change propofol Ce increments 0.5 µg/mL ( range , 1-4.5 µg/mL ) every 3 minute necessary maintain SE &lt; 50 , RE-SE difference &lt; 10 , MAP heart rate ( HR ) ≤20 % baseline value . The remifentanil Ce increase maximum 3 increment 0.5 ng/mL SE &gt; 50 , RE-SE difference &gt; 10 , MAP HR ≥20 % baseline value despite target propofol Ce &gt; 4.5 µg/mL . When SE &lt; 50 RE-SE difference &lt; 10 , propofol Ce decrease gradually ≥1 µg/mL , follow gradual decrease remifentanil Ce 0.5 ng/mL , randomize Ce achieve . Based pilot study , author consider use 0.5-ng/mL increment remifentanil Ce would obtund entropy hemodynamic response noxious stimulus . The author expect 4 remifentanil Ce increments 0.5 ng/mL would double infusion rate Ce 1-ng/mL group 2 ng/mL ( [ 0.5 ng/mL x 4 ] + 1 ng/mL ) . The HR MAP keep within 20 % baseline value achieve adequate depth anesthesia ( SE &lt; 50 RE-SE difference &lt; 10 ) , optimum analgesia , administration nitroglycerin , 0.05 mg , esmolol , 20 mg. Cisatracurium , 1 3 µg/kg/min , use maintain surgical relaxation . All patient receive tranexamic acid , 50 mg/kg . Light anesthesia define episode SE value &gt; 50 and/or MAP HR value &gt; 20 % baseline last &gt; 3 consecutive minute . The incidence light anesthesia response intubation , skin incision , sternotomy , maximal sternal spread , sternal wire placement record . Hemodynamic control standardize accord author ' protocol . Hypotension ( define &gt; 20 % decrease mean baseline MAP ) treat bolus fluid , phenylephrine 200 µg , ephedrine 5 mg , epinephrine , 5 µg , need . Hypertension ( define &gt; 20 % increase mean baseline MAP ) treat deepen anesthesia administer dos nitroglycerin , 0.05 mg , labetalol , 20 mg. Tachycardia ( define &gt; 20 % increase mean baseline HR ) treat esmolol , 20 mg. All operation perform surgeon . Heparin , 300 IU/kg , give achieve activate coagulation time &gt; 480 second . A standardized hypothermic cardiopulmonary bypass ( CPB ) use . The target propofol Ce remifentanil Ce continue throughout surgery CPB without adjustment CPB per se . Before separation CPB , patient rewarmed rectal temperature 36°C dobutamine , epinephrine , norepinephrine , nitroglycerin use need . Heparin neutralized protamine sulfate . The cisatracurium infusion discontinue morphine 0.1 mg/kg administer intravenously surgical homeostasis achieve . The target remifentanil Ce propofol Ce discontinue skin closure . The HR , MAP , cardiac systemic vascular resistance index record ( baseline ) 15 minute endotracheal intubation , 15 minute skin incision , 15 minute sternotomy , 15 45 minute discontinue CPB . Patients transfer intensive care unit ( ICU ) ventilate state use synchronized intermittent mandatory mode pressure support mode . Postoperative analgesia provide intravenous paracetamol , lornoxicam , patient-controlled analgesia ( PCA ) , morphine 1 mg , lockout interval 8 minute maximum 4-hourly limit 30 mg. Extubation criterion include alertness , train-of-four ratio ≥0.9 , spontaneous breathe tidal volume &gt; 5 mL/kg , respiratory rate &gt; 10 &lt; 28 breaths/min , maximum inspiratory pressure ≤-20 cm H2O , stable hemodynamics without high dos inotropic support severe arrhythmia , bleed &lt; 100 mL/h , core temperature &gt; 35.5°C , urine output &gt; 0.5 mL/ kg/h , arterial carbon dioxide tension ≤45 mmHg , arterial oxygen tension &gt; 100 mmHg , fraction inspire oxygen &lt; 0.5 . Blood sample draw CPB 3 , 12 , 24 , 48 hour CPB measure cardiac troponin I level . Intraoperative explicit awareness assess second postoperative day ask patient 3 simple question standard interview : What last thing remember happen go sleep ? What first thing remember happen wake ? Did dream experience asleep ? An independent investigator blind study group involve patient ' management collect patient data . Sample size calculation : A priori power analysis publish data show normally distribute mean time tracheal extubation remifentanil , 7 ng/mL , 256 minute ( SD , 92 min ) . An priori power analysis indicate sample size 23 group sufficiently large detect 35 % change time extubation administration remifentanil Ce , 7 ng/mL , type-I error 0.017 ( 0.05/3 possible comparison ) power 90 % . This sample size increase 10 % compensate patient drop study . In view amend protocol 2015 compare low remifentanil Ce 1 , 2 , 3 ng/ml rather earlier consider 3 high concentration ( 2 , 5 , 7 ng/ml ) note significant haemodynamic compromise require high use inotropes/vasopressors , earlier consider sample size calculation valid anymore . Thus recruited case pilot study . A pilot study show normally distribute mean time tracheal extubation remifentanil , 3 ng/mL , 39 minute ( SD , 14.92 min ) . An priori power analysis indicate sample size 21 group sufficiently large detect 15 min difference time extubation administration remifentanil Ce , 3 ng/mL , type-I error 0.017 ( 0.05/3 possible comparison ) power 90 % . This sample size increase 10 % account patient drop study . Statistical Analysis The data test normality use Kolmogorov-Smirnov test . Repeated-measures analysis variance use analyze serial change patient data different time . The Fisher exact test use categorical data . Repeated measure analysis variance ( ANOVA ) use continuous parametric variable difference correct post hoc Bonferroni test . The Kruskal-Wallis test perform intergroup comparison nonparametric value post hoc pairwise comparison perform use Wilcoxon rank-sum test . The data express mean ( SD ) , number ( percentage ) , median [ range ] . A p value &lt; 0.05 consider represent statistical significance .</detailed_description>
	<mesh_term>Remifentanil</mesh_term>
	<criteria>18 65 year old American Society Anesthesiologists class III IV eligible early extubation uncontrolled hypertension ischemic heart disease leave ventricular ejection fraction ≤45 % mean pulmonary artery pressure ≥50 mm Hg critical aortic stenosis pulmonary disease hepatic disease renal disease neuromuscular disease neuropsychiatric disease endocrine disease body mass index ≥40 kg/m2 pregnancy use antipsychotic use alcohol drug abuse repeat surgery emergency surgery require preoperative circulatory support whose electrocardiographic characteristic would interfere STsegment monitoring</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Anesthesia</keyword>
	<keyword>remifentanil</keyword>
	<keyword>propofol</keyword>
	<keyword>target-controlled infusion</keyword>
	<keyword>cardiac surgery</keyword>
</DOC>